|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
107,850,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
124,527 |
289,711 |
366,947 |
559,547 |
Total Sell Value |
$8,826,266 |
$19,152,247 |
$23,008,468 |
$28,095,276 |
Total People Sold |
5 |
6 |
6 |
8 |
Total Sell Transactions |
16 |
36 |
45 |
80 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-12-07 |
4 |
AS |
$56.50 |
$565,000 |
D/D |
(10,000) |
21,035 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-12-07 |
4 |
OE |
$21.41 |
$214,100 |
D/D |
10,000 |
31,035 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-12-01 |
4 |
AS |
$51.43 |
$136,442 |
I/I |
(2,618) |
152,594 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2023-12-01 |
4 |
AS |
$51.46 |
$156,408 |
D/D |
(3,000) |
175,935 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2023-12-01 |
4 |
OE |
$2.42 |
$7,260 |
D/D |
3,000 |
178,935 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-11-24 |
4 |
AS |
$48.96 |
$736,300 |
D/D |
(15,000) |
370,914 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-11-20 |
4 |
AS |
$51.12 |
$409,063 |
D/D |
(8,000) |
79,474 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-11-20 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
|
- |
|
Paya Carlos V |
Director |
|
2023-11-09 |
4 |
A |
$0.00 |
$0 |
I/I |
3,125 |
3,125 |
|
- |
|
Paya Carlos V |
Director |
|
2023-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,125 |
2,500 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-10-23 |
4 |
AS |
$46.98 |
$706,070 |
D/D |
(15,000) |
385,914 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-10-18 |
4 |
AS |
$45.89 |
$367,300 |
D/D |
(8,000) |
79,474 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-10-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2023-10-12 |
4 |
OE |
$2.42 |
$12,100 |
D/D |
5,000 |
175,935 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2023-10-02 |
4 |
AS |
$49.69 |
$151,298 |
D/D |
(3,000) |
170,935 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2023-10-02 |
4 |
OE |
$2.42 |
$7,260 |
D/D |
3,000 |
173,935 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-10-02 |
4 |
AS |
$49.58 |
$1,007,989 |
D/D |
(20,000) |
20,487 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-10-02 |
4 |
OE |
$21.41 |
$428,200 |
D/D |
20,000 |
40,487 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-10-02 |
4 |
AS |
$49.67 |
$131,996 |
I/I |
(2,618) |
155,212 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-09-25 |
4 |
AS |
$52.42 |
$137,264 |
I/I |
(2,618) |
156,521 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-09-25 |
4 |
AS |
$52.45 |
$786,794 |
D/D |
(15,000) |
400,914 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2023-09-22 |
4 |
OE |
$2.42 |
$7,260 |
D/D |
3,000 |
170,935 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-09-05 |
4 |
D |
$51.00 |
$181,968 |
D/D |
(3,568) |
79,474 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-09-05 |
4 |
D |
$51.00 |
$60,639 |
D/D |
(1,189) |
20,487 |
|
- |
|
Cowan Elvia |
SVP, Finance |
|
2023-09-05 |
4 |
D |
$51.00 |
$31,977 |
D/D |
(627) |
7,301 |
|
- |
|
355 Records found
|
|
Page 4 of 15 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|